B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co

Joint marketing of CytoSorb® with B. Braun’s newest OMNI® blood purification platform will offer greater access of this advanced treatment of deadly inflammation to critically ill patients. MELSUNGEN, Germany and MONMOUTH JUNCTION, N.J., March 2, 2021 /PRNewswire/ — B. Braun Avitum AG, a leading manufacturer of medical devices and pharmaceutical products and services and CytoSorbents Corporation […]

Organization, Facts & Figures

In this image released on Tuesday, March 2, 2021, the OMNI

Newsroom

Digital Workplace for B. Braun

In this image released on Tuesday, March 2, 2021, the CytoSorb® adsorber is used in critical care for the extracorporeal removal of cytokines and inflammatory mediators from the bloodstream. B. Braun Avitum

Hip Replacement Devices Market Size, Share, Trends, Scope & Forecast

B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement

Global Oncology

Company